Literature DB >> 4208276

Comparison of colistin-carbenicillin, colistin, and carbenicillin in Pseudomonas sepsis in monkeys.

S Saslaw, H N Carlisle, M Moheimani.   

Abstract

Intravenous inoculation of 6.2 x 10(10) to 6.7 x 10(10)Pseudomonas aeruginosa organisms into rhesus monkeys 5 days after intratracheal inoculation of 2.0 to 2.5 mg of vincristine sulfate resulted in fatal sepsis in 8 of 10 untreated monkeys. When similarly infected monkeys were treated intramuscularly with 2.5 mg of colistin or 50 mg of carbenicillin per kg per day, all three monkeys in each treatment group survived; one of three monkeys receiving both antibiotics at the above doses died. Six of seven monkeys treated with 1.25 mg of colistin per kg per day and three of seven treated with 25 mg of carbenicillin per kg per day died; four of nine monkeys receiving both antibiotics at these doses died. A combination of the data obtained at both dose levels tested shows that 6 of 10, 3 of 10, and 5 of 12 monkeys, respectively, died after treatment with colistin, carbenicillin, and the colistin-carbenicillin combination. Antibacterial activity of serum from both infected and normal monkeys was not appreciably different when the two antibiotics were given singly or in combination. Under the conditions of this study and with the doses employed, the response of monkeys treated with the antibiotic combination did not differ significantly from that of monkeys treated with a single agent.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4208276      PMCID: PMC444370          DOI: 10.1128/AAC.3.1.118

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy.

Authors:  S D Davis; A Iannetta; R J Wedgwood
Journal:  J Infect Dis       Date:  1971-07       Impact factor: 5.226

2.  Nonhuman primates in evaluation of hematotoxicity.

Authors:  S Saslaw; H N Carlisle
Journal:  Ann N Y Acad Sci       Date:  1969-07-03       Impact factor: 5.691

3.  Studies on therapy of staphylococcal infections in monkeys. 3. Comparison of cephalothin, cephaloridine and cephalexin.

Authors:  S Saslaw; H N Carlisle
Journal:  Am J Med Sci       Date:  1968-09       Impact factor: 2.378

4.  Comparison of cephalothin, cephaloridine, cephalexin and cephaloglycin in streptococcal infections in monkeys.

Authors:  S Saslaw; H N Carlisle
Journal:  Am J Med Sci       Date:  1969-06       Impact factor: 2.378

5.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

6.  Studies on cephalosporin therapy of experimental streptococcal and staphylococcal infections in monkeys.

Authors:  S Saslaw
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

7.  Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

Authors:  S Schimpff; W Satterlee; V M Young; A Serpick
Journal:  N Engl J Med       Date:  1971-05-13       Impact factor: 91.245

8.  Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin in streptococcal infections in monkeys.

Authors:  S Saslaw; H N Carlisle
Journal:  Am J Med Sci       Date:  1970-06       Impact factor: 2.378

9.  Comparison of tobramycin, gentamicin, colistin, and carbenicillin in Pseudomonas sepsis in monkeys.

Authors:  S Saslaw; H N Carlisle; M Moheimani
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

10.  Effect of vincristine sulfate on Pseudomonas infections in monkeys.

Authors:  S Saslaw; H N Carlisle; M Moheimani
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

View more
  1 in total

1.  Comparison of gentamicin, carbenicillin and gentamicin, and carbenicillin in Pseudomonas sepsis in monkeys.

Authors:  S Saslaw; H N Carlisle; M Moheimani
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.